ALA 3.13% 15.5¢ arovella therapeutics limited

25 cents and beyond, page-2

  1. 640 Posts.
    lightbulb Created with Sketch. 172
    And you will get your post moderated.
    There are so many holes in your post I don't know where to start..
    NDF research is PAID that means it is biased and not a guaranteed or even accurate assessment. It represents what Sud want investors to know. The rest is your opinion.

    What has been discussed is negative, but good business involves assessing and managing risk. The fact that purple unicorns with wings who will shortly deliver huge bags of money can't fly when there is negative energy in the cosmos is an opinion. Doesn't make it fact.

    Shareholders are not friends. They are in it for the growth, not of friendship, of $$ and have made decisions to invest $$ that Sud management are held accountable. This is not a popularity contest and requires 720 vision and analysis/fact, not touchy-feely friendship vibes.

    SC also was a key player in why we now have the HC BP debacle hanging over Sud. As TGA so eloquently summed up:
    July 2010 - Administrator requests manufacture rights be registered with patent
    August 2010 - EMS taking steps to do this
    September 2010 - Administrator once confirmed any claim will cease to endure
    October 2010 - Stephen Carter joins EMS and doesn't appear to follow through
    https://www.asx.com.au/asxpdf/20110706/pdf/41zmmjs96gkwbz.pdf

    He did not do this on his own, MS was right beside him making that decision/dropping that ball. If if was a ball drop, it was a very big ball
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.